DOTA-ECL1i

SKU: orb3212306

Description

DOTA-ECL1i is a conjugate of the CCR2 inhibitor ECL1i and DOTA. When labeled with the radioisotope 68Ga, DOTA-ECL1i serves as a PET tracer targeting CCR2 expression. It is applicable in research related to pulmonary fibrosis, cardiac injury, abdominal aortic aneurysm inflammation, atherosclerosis, head and neck cancer, and pancreatic cancer.

Key Properties

• Target: CCR
• CAS Number: 2850189-48-7
• MW: 1307.52
• Formula: C₅₈H₉₄N₁₄O₁₈S
• SMILES: S(C[C@@H](NC([C@H](NC([C@H](NC([C@@H](CC1=CC=CC=C1)NC([C@H](NC(CNC([C@@H](CC(C)C)N)=O)=O)[C@H](C)O)=O)=O)CC(C)C)=O)CCCCN)=O)C(O)=O)C2C(=O)N(CCNC(CN3CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC3)=O)C(=O)C2

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Quick Database Links

Gene Symbol

CCR